ArticleEuropean journal of pharmacology2011

C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells.

Eleonora Brognara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.